4 New HIV specific latency reversing agents with novel targets that synergise with HIV Tat and the bromodomain inhibitor, JQ1 to reactivate HIV from primary cells

J. Jacobson, B. Sleebs, K. Jarman, W. Nguyen, T. Mota, L. Harty, G. Khoury, N. Tay, P. Cameron, S. Lewin, D.F.J. Purcell
2017 Journal of virus eradication  
doi:10.1016/s2055-6640(20)30709-3 fatcat:hjpxp3i6rfar3nby62hbcfkzcy